SAN FRANCISCO, Artificial intelligence has yet to deliver on the most challenging aspect of drug development -- finding...
Read More
In a significant development that signals a new phase of India-Afghanistan economic cooperation and a blow to Pakistan's...
Read More
Once focused on low-margin active pharmaceutical ingredients (APIs), India's bulk drug manufacturers are raising their...
Read More
Zydus Lifesciences on Thursday said it has received approval from the US health regulator to market a generic diabetes...
Read More
The US and China may have called a truce on trade, but Beijing has other levers to pull should febrile relations...
Read More
Global drugmakers are rushing to boost U.S. manufacturing and inventory as the Trump administration weighs a 100% tariff...
Read More
The German conglomerate is trying to turn around its pharmaceutical business, which has been hit in recent years by...
Read More
Lilly shares closed at $1,059.70 on Friday, giving it a market cap slightly above the 13-figure milestone.
...
Read More
GLOBAL FAILURE TO ADAPT TO climate change is taking a toll on people's lives and is responsible for millions of deaths...
Read More
The rules come at a time when advertisements of potent antibiotics, psychotropic drugs, hormonal therapies, and...
Read More
Healthcare industry body Nathealth has asked the government to declare the sector as core infrastructure and create a...
Read More
India has begun talks with China on a reverse-trade model under which bulk drugs imported from China would be converted...
Read More